Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Long Term Follow-up After Embolization of Brain Arteriovenous Malformations (MAV-endovasc)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02879071
Recruitment Status : Recruiting
First Posted : August 25, 2016
Last Update Posted : June 1, 2020
Sponsor:
Information provided by (Responsible Party):
Fondation Ophtalmologique Adolphe de Rothschild

Brief Summary:
The time-frame and the follow-up elements after embolization of brain arteriovenous malformations are not standardized. Therefore, few reliable follow-up data are available for these patients. This study aims at collecting standardized long term data for these patients.

Condition or disease
Arteriovenous Malformations

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Long Term Follow-up After Embolization of Brain Arteriovenous Malformations
Study Start Date : November 26, 2015
Estimated Primary Completion Date : November 2020
Estimated Study Completion Date : November 2020

Resource links provided by the National Library of Medicine





Primary Outcome Measures :
  1. angiographic evaluation of the arteriovenous malformation occlusion [ Time Frame: 5 years after embolization ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients undergoing embolization for an arteriovenous malformation
Criteria

Inclusion Criteria:

  • arteriovenous malformation
  • age > 18 years old

Exclusion Criteria:

  • none

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02879071


Contacts
Layout table for location contacts
Contact: Laurence Salomon, MD +33 1 48 03 64 31 lsalomon@fo-rothschild.fr

Locations
Layout table for location information
France
Fondation Ophtalmologique Adolphe de Rothschild Recruiting
Paris, France, 75019
Principal Investigator: Raphaël Blanc, MD         
Sponsors and Collaborators
Fondation Ophtalmologique Adolphe de Rothschild
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Fondation Ophtalmologique Adolphe de Rothschild
ClinicalTrials.gov Identifier: NCT02879071    
Other Study ID Numbers: RBC_2015_17
First Posted: August 25, 2016    Key Record Dates
Last Update Posted: June 1, 2020
Last Verified: May 2020
Additional relevant MeSH terms:
Layout table for MeSH terms
Hemangioma
Arteriovenous Malformations
Congenital Abnormalities
Vascular Malformations
Cardiovascular Abnormalities
Cardiovascular Diseases
Vascular Diseases
Neoplasms, Vascular Tissue
Neoplasms by Histologic Type
Neoplasms